JERUSALEM, April 22, 2013 /PRNewswire/ --
Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a developer of oral delivery systems, announced today that the Company's CEO Nadav Kidron has been invited to be a panelist for a breakouts session at the BIO International Convention in Chicago, Illinois, USA. The breakout session, titled "Can Israel Become the Next Biotech Start-Up Nation?" will take place on Tuesday, April 23rd, from 9:00-9:45am during the International Market Briefings Track.
In the last 20 years, Israel has become a model for high tech entrepreneurship. A country of 8 million people, Israel is home to a vibrant academic biomedical research sector, a global pharmaceutical company and several public biotech companies. Yet, the success of Israel's biotech sector pales in comparison to its high-tech industry. What can be learned from the Israeli Hi-tech Innovation and Entrepreneurship model and how can it be applied to biotech? What can Israel learn from other success models in biotechnology such as Massachusetts or California? Which regional partnerships can best leverage Israel's potential? What is the optimal positioning for Israeli Biotech to encourage biopharma companies and investors to step up their involvement?
For more information on the panel please visit: http://mybio.zerista.com/event/member/64237
The BIO International Conventio
|SOURCE Oramed Pharmaceuticals Inc.|
Copyright©2012 PR Newswire.
All rights reserved